Free Trial

Cellebrite DI (CLBT) Earnings Date, Estimates & Call Transcripts

Cellebrite DI logo
$17.50 -0.20 (-1.13%)
(As of 03:00 PM ET)

Cellebrite DI Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 20Estimated
Actual EPS
(Nov. 6)
$0.14 Beat By $0.05
Consensus EPS
(Nov. 6)
$0.09

Cellebrite DI announced Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.14, which beat analysts' consensus estimates of $0.09 by $0.05. Quarterly revenue rose 27.0% year-over-year to $106.90 million, above the consensus estimate of $102.06 million. With a trailing EPS of -$1.55, Cellebrite DI's earnings are expected to decrease -6.25% next year, from $0.32 to $0.30 per share.

CLBT Upcoming Earnings

Cellebrite DI's next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules.

Get Cellebrite DI Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cellebrite DI and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLBT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLBT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellebrite DI Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20241$0.08$0.08$0.08
Q3 20241$0.09$0.09$0.09
Q4 20241$0.11$0.11$0.11

Cellebrite DI Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/20/2025
(Estimated)
------- 
11/6/2024Q3 2024$0.09$0.14+$0.05$1.21$102.06M$106.90M        
8/15/2024Q2 2024$0.08$0.10+$0.02$0.32$91.94M$95.70M        
5/23/2024Q1 2024$0.06$0.08+$0.02$0.52$85.34M$89.60M        
2/15/2024Q4 2023$0.06$0.08+$0.02$0.24$85.43M$93.01M    
11/14/2023Q3 2023$0.01$0.09+$0.08$0.15$82.13M$84.20M        
8/8/2023Q2 2023$0.03$0.05+$0.02$0.27$72.52M$76.70M        
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

5/10/2023Q1 2023$0.03$0.03-$0.27$69.42M$71.23M    
2/15/2023Q4 2022$0.04$0.06+$0.02$0.08$74.78M$74.02M    

Cellebrite DI Earnings - Frequently Asked Questions

Cellebrite DI has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on CLBT's earnings history.

Cellebrite DI updated its fourth quarter 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $105.0 million-$109.0 million, compared to the consensus revenue estimate of $106.8 million.

In the previous quarter, Cellebrite DI (NASDAQ:CLBT) reported $0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $0.09 by $0.05. Learn more on analysts' earnings estimate vs. CLBT's actual earnings.

The conference call for Cellebrite DI's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Cellebrite DI's latest earnings report can be read online.
Read Transcript

Cellebrite DI (NASDAQ:CLBT) has a recorded annual revenue of $325.11 million.

Cellebrite DI (NASDAQ:CLBT) has a recorded net income of -$81.10 million. CLBT has generated -$1.55 earnings per share over the last four quarters.

Cellebrite DI (NASDAQ:CLBT) has a forward price-to-earnings ratio of 54.69. The price/earnings-to-growth ratio is 2.41.

Cellebrite DI's earnings are expected to decrease from $0.32 per share to $0.30 per share in the next year, which is a -6.25% change.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CLBT) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners